JEFFREY J. KIMBELL & ASSOCIATES, INC.

Lobbying for INSTITUTE FOR GENE THERAPIES · Advocacy organization

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $20,000.00 income · posted Jan 20, 2026

Bills named in this filing 1

Lobbying activity 2

Medicare/Medicaid

Issues related to reimbursement for gene therapies. H.R. 7389, MVP Act of 2022

Health Issues

Issues related to the regulation of gene therapies; newborn screening; FDA appropriations

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.